Status:
COMPLETED
Intestinal Permeability, Nutritional Status and Quality of Life in Celiac Disease
Lead Sponsor:
Marmara University
Conditions:
Celiac Disease
Nutritional Deficiency
Eligibility:
All Genders
18-64 years
Brief Summary
Celiac disease is defined as an autoimmune enteropathy with malabsorption of gluten protein. In recent studies, it has been stated that in individuals diagnosed with celiac disease, intestinal epithel...
Detailed Description
Celiac disease is defined as an autoimmune enteropathy that progresses with malabsorption of gluten protein found in wheat, barley, rye and small intestinal mucosal inflammation in individuals with ge...
Eligibility Criteria
Inclusion
- To be between the ages of 18-64,
- To be literate,
- To have positive serological anti tissue transglutaminase immunoglobulin A antibodies value,
- To have a small intestinal biopsy proven celiac disease diagnosis at the time of gastrointestinal endoscopy
- To be volunteer by signing the informed consent form.
Exclusion
- To have another autoimmune disease such as type 1 diabetes, psoriasis, hashimoto's thyroiditis, rheumatoid arthritis, systemic lupus erythematosus,
- To be in pregnancy or lactation period,
- Taking probiotic/ prebiotics supplements in the last 2 months,
- Taking antibiotics or non-steroidal antiinflammatory drugs in the last 1 week.
Key Trial Info
Start Date :
November 5 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 19 2019
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04351828
Start Date
November 5 2018
End Date
April 19 2019
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University Institute of Health Sciences
Istanbul, Maltepe, Turkey (Türkiye), 34